Case report: COVID-19 mRNA vaccine association with acute myocarditis

Abstract: A 50-year-old woman presented to the Emergency Department with chest pain, the elevation of cardiac enzymes, and no electrocardiographic alterations. Coronary angiography was performed in which no obstructive lesions were found. A cardiac magnetic resonance study reported an image consistent with acute myocarditis without evidence of myocardial ischemia. The patient received the first dose of Pfizer-BioNTech vaccine two days before the onset of symptoms. In most cases of myocarditis, its clinical manifestations lie in a wide spectrum, and the etiological diagnosis is indeterminate. In recent months, the probable association between cases of myocarditis with COVID-19 mRNA vaccines has been established. The use of the COVID-19 mRNA vaccine has demonstrated significant benefits in reducing morbidity and mortality related to SARS-CoV-2 virus infection. This event may be a transitory process that does not represent a contraindication for the application of the vaccine.

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pérez-Orpinel,Oscar A, Figuerola-Chaparro,Luis C, Fernández-Rosas,Susana, Moreno-Zamudio,Daniela, Mendoza-González,Celso A
Format: Digital revista
Langue:English
Publié: Asociación Nacional de Cardiólogos de México A.C. 2022
Accès en ligne:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2954-38352022000200069
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!